October 27, 2020 News Proteintech, the benchmark in antibodies, announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies. You Might Also Like Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19 December 3, 2020 Proteintech Group Acquires Manufacturer of Human Cell-Expressed Proteins, HumanZyme April 16, 2018 Quanterix Receives FDA Emergency Use Authorization For SARS-CoV-2 N Protein Antigen Test January 25, 2021
Quanterix Receives FDA Emergency Use Authorization For SARS-CoV-2 N Protein Antigen Test January 25, 2021